The challenges of drug development can increase if a manufacturer assumes an existing formulation for an adult can also be used for a child. Pediatric drug development requires a formulation designed to fit the specific needs of that patient population. Not considering these requirements early enough could add significant delays.
There’s no doubt: around the world, people are living longer. And older people tend to take more medications than others do, but with age comes medication challenges. Many older people prefer softgel formulations, which are easier to swallow than tablets or caplets. Softgels can also be a better option than liquids, which can be messy when handled by people whose hands are not as steady as they once were.
This webinar discusses potential mechanisms of increased absorption with lipid formulations and appropriate screening tools that are used during the development approach of these formulations. Also covered are subsequent steps to scale up and industrialize these formulations.
Softgels are becoming an increasingly popular dosage form in both the prescription (Rx) and over the counter (OTC) markets. With decades of experience and capabilities spanning development through commercialization, Thermo Fisher Scientific’s softgel experts understand what it takes to maximize the potential of your product in either market.